PRGB Insider Trading Activity and SEC Form 4 Filings
PRGB insider trading summary
No open-market insider purchases or sales of Protea Biosciences Group, Inc. (PRGB) have been reported on SEC Form 4 in the past 12 months.
Latest PRGB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2016 | Stanley Hostler | Director | Buy | $22K (293,333 @ $0.07) |
| Sep 20, 2016 | Stanley Hostler | Director | Buy | $5K (50,000 @ $0.10) |
| Jul 25, 2016 | Stephen C Turner | Chief Executive Officer | Buy | $3K (20,000 @ $0.15) |
| Jul 5, 2016 | Stephen C Turner | Chief Executive Officer | Buy | $4K (24,000 @ $0.15) |
| Jul 5, 2016 | Leonard P Harris | Director | Buy | $11K (70,000 @ $0.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.